Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Access to Document

@article{73910a26dd654a9cb008e734e51a99d2,

title = "Editorial: Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis",

author = "Affandi, {Alsya J.} and {van Roon}, {Joel A.G.}",

year = "2016",

month = nov,

day = "1",

doi = "10.1002/art.39815",

language = "English",

volume = "68",

pages = "2571--2574",

journal = "Arthritis and Rheumatology",

issn = "2326-5191",

publisher = "John Wiley & Sons Inc.",

number = "11",

}

TY - JOUR

T1 - Editorial

T2 - Closing in on the Role of Thymic Stromal Lymphopoietin Inhibition as a Therapeutic Entry Point for Systemic Sclerosis

AU - Affandi, Alsya J.

AU - van Roon, Joel A.G.

PY - 2016/11/1

Y1 - 2016/11/1

UR - http://www.scopus.com/inward/record.url?scp=84990879516&partnerID=8YFLogxK

U2 - 10.1002/art.39815

DO - 10.1002/art.39815

M3 - Editorial

C2 - 27428811

AN - SCOPUS:84990879516

SN - 2326-5191

VL - 68

SP - 2571

EP - 2574

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

IS - 11

ER -